DMPI - DelMar Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 59.45M
Enterprise Value 312.12M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-68.37%
Return on Equity (ttm)-126.15%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-10.63M
Diluted EPS (ttm)-0.467000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.88M
Total Cash Per Share (mrq)0.17
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.39
Book Value Per Share (mrq)-0.12

Cash Flow Statement

Operating Cash Flow (ttm)-9.56M
Levered Free Cash Flow (ttm)-5.67M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.12
52-Week Change 3-71.45%
S&P500 52-Week Change 3-6.95%
52 Week High 31.590000
52 Week Low 30.310000
50-Day Moving Average 30.410937
200-Day Moving Average 30.566810

Share Statistics

Avg Vol (3 month) 390.21k
Avg Vol (10 day) 357.28k
Shares Outstanding 522.56M
Float 19.91M
% Held by Insiders 18.66%
% Held by Institutions 16.90%
Shares Short (Dec 31, 2018) 4642.18k
Short Ratio (Dec 31, 2018) 45.58
Short % of Float (Dec 31, 2018) 43.06%
Short % of Shares Outstanding (Dec 31, 2018) 42.85%
Shares Short (prior month Nov 30, 2018) 4836.22k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 24/1
Last Split Date 3May 20, 2016